[1]CurrentPatentAssignee:BAYERAG-US2013/196964,2013,A1Locationinpatent:Paragraph1101;1102;1103
[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2008/300242,2008,A1Locationinpatent:Page/Pagecolumn74
[3]CurrentPatentAssignee:ELILILLY&CO-US2010/160288,2010,A1Locationinpatent:Page/Pagecolumn17
[4]CurrentPatentAssignee:ELILILLY&CO-WO2011/123482,2011,A1Locationinpatent:Page/Pagecolumn16
[5]CurrentPatentAssignee:ELILILLY&CO-US2011/245255,2011,A1Locationinpatent:Page/Pagecolumn10
[6]CurrentPatentAssignee:ASTELLASPHARMAINC.-US2012/184520,2012,A1Locationinpatent:Page/Pagecolumn17
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2008/300242,2008,A1Locationinpatent:Page/Pagecolumn74-75
[1]CurrentPatentAssignee:SANOFI-US2010/152157,2010,A1Locationinpatent:Page/Pagecolumn13-14
[1]CurrentPatentAssignee:EFFECTORTHERAPEUTICSINC;EFFECTTHERAPYSTOCKLTDCOMPANY-WO2021/3157,2021,A1Locationinpatent:Paragraph0169;0194
[1]CurrentPatentAssignee:CASMATHERAPEUTICS;KASMATHERAPEUTICS-WO2021/127337,2021,A1Locationinpatent:Paragraph0508